Financial statements Vilapharm
Balance sheet of Vilapharm
Company age:
Age:
8 y. 7 m. 27 d.
Share capital:
Share capital:
6 000 PLN
Balance sheet data of VILAPHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 5 054,04 | 5 054,04 | 170 360,70 | 34 992,31 | 211 595,32 | 517 491,62 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 10 878,05 | 9 246,34 | 7 070,73 |
| B. Current assets | 5 054,04 | 5 054,04 | 170 360,70 | 24 114,26 | 202 348,98 | 510 420,89 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 5 054,04 | 5 054,04 | 170 360,70 | 34 992,31 | 211 595,32 | 517 491,62 |
| A. Equity | 5 054,04 | 5 054,04 | 899,70 | -123 170,76 | 162 655,52 | 511 100,24 |
| B. Liabilities and provisions for liabilities | 0,00 | 0,00 | 169 461,00 | 158 163,07 | 48 939,80 | 6 391,38 |
| I. Long-term liabilities | - | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.